首页|Exploring the ethics of genetic prioritisation for COVID-19 vaccines
Exploring the ethics of genetic prioritisation for COVID-19 vaccines
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Springer Nature
There is evidence to suggest that host genomic factors may account for disease response variability in COVID-19 infection. In this paper, we consider if and how host genomics should influence decisions about vaccine allocation. Three potential host genetic factors are explored: vulnerability to infection, resistance to infection, and increased infectivity. We argue for the prioritisation of the genetically vulnerable in vaccination schemes, and evaluate the potential for ethical de-prioritisation of individuals with genetic markers for resistance. Lastly, we discuss ethical prioritisation of individuals with genetic markers for increased infectivity (those more likely to spread COVID-19).
NSTL
Springer Nature
